Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24974461 | 0.77 | — | — | |
| SCHEMBL21340911 | 0.77 | CPA1 (0.36) | CPA1CPB2 | |
| SCHEMBL20353525 | 0.77 | — | — | |
| SCHEMBL21024540 | 0.75 | CPA1 (0.34) | CPA1CPB2 | |
| SCHEMBL20903991 | 0.75 | — | — | |
| SCHEMBL19099588 | 0.73 | CPA1 (0.39) | CPA1CPB2 | |
| SCHEMBL24272193 | 0.73 | ACHE (0.39) | — | |
| SCHEMBL18639308 | 0.72 | IDO1 (0.32) | — | |
| SCHEMBL12039663 | 0.72 | CPA1 (0.41) | CPA1CPB2 | |
| SCHEMBL21480920 | 0.70 | IDO1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10301284-B2 | Therapeutic inhibitory compounds | LIFESCI PHARMACEUTICALS, INC. (BB) | 2019-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10301284-B2 | Therapeutic inhibitory compounds | KLKB1, SERPINB1, SERPINE1 | CPA1 119/4885CPB2 201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.